News
Watch
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Health Systems|

Pharmacy Technician|

Douglas A. Nemecek, MD

Articles by Douglas A. Nemecek, MD

Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population

ByJulie B. Kessel, MD,Liana D. Castel, PhD,Douglas A. Nemecek, MD

February 2nd 2018

Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.

Latest Updated Articles

Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population
February 2nd 2018

Trending on Pharmacy Times

Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC

Could CAR T Therapy Become Adjustable After Infusion?